Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyLeukemia(58 courses)
All specialties

Leukemia

58 courses

2026 AIO | Acute Myeloid Leukemia: Recent NEJM Insights

2026 AIO | Acute Myeloid Leukemia: Recent NEJM Insights

0.00 Credits
1 Chapter
Leukemia
Free
2026 AIO | Recent Advances in Acute Leukemias

2026 AIO | Recent Advances in Acute Leukemias

0.00 Credits
1 Chapter
Leukemia
Free
2026 MCM | MDS in 2026: Challenges and Opportunities

2026 MCM | MDS in 2026: Challenges and Opportunities

0.00 Credits
1 Chapter
Leukemia
Free
2026 MCM | Management of High-Risk AML

2026 MCM | Management of High-Risk AML

0.00 Credits
1 Chapter
Leukemia
Free
2026 MCM | Are We Getting Functional CURE of CLL?

2026 MCM | Are We Getting Functional CURE of CLL?

0.00 Credits
1 Chapter
Leukemia
Free
2025 Advances in Oncology | Recent Advances in Acute Leukemias/MDS

2025 Advances in Oncology | Recent Advances in Acute Leukemias/MDS

0.00 Credits
1 Chapter
Leukemia
Free
2025 NOSCM | Genomics in Treatment Decision for De Novo Acute Myeloid Leukemia

2025 NOSCM | Genomics in Treatment Decision for De Novo Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
2025 NOSCM | CLL: Therapeutic Advances in 2025

2025 NOSCM | CLL: Therapeutic Advances in 2025

0.00 Credits
1 Chapter
Leukemia
Free
2025 MCM | Acute Myeloid Leukemia

2025 MCM | Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
2025 MCM | Chronic Lymphocytic Leukemia

2025 MCM | Chronic Lymphocytic Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
2024 MCM | Myelodysplasia: De Novo and Acquired- What To Do?

2024 MCM | Myelodysplasia: De Novo and Acquired- What To Do?

0.00 Credits
1 Chapter
Leukemia
Free
2023 UCT | New Developments in CLL

2023 UCT | New Developments in CLL

0.00 Credits
1 Chapter
Leukemia
Free
Case Presentation: CLL

Case Presentation: CLL

0.00 Credits
1 Chapter
Leukemia
Free
2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

0.00 Credits
1 Chapter
Leukemia
Free
2024 NOSCM | CLL: Therapeutic Advances in 2024

2024 NOSCM | CLL: Therapeutic Advances in 2024

0.00 Credits
1 Chapter
Leukemia
Free
Acute Myeloid Leukemia

Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
2024 NOSCM | Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

2024 NOSCM | Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2)

0.00 Credits
1 Chapter
Leukemia
Free
The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia

The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
CLL and CML

CLL and CML

0.00 Credits
1 Chapter
Leukemia
Free
2022 CCC | Advance in Treatment of Acute Lymphocyctic Leukemia

2022 CCC | Advance in Treatment of Acute Lymphocyctic Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
AML and MDS: Current Status and Future Directions

AML and MDS: Current Status and Future Directions

0.00 Credits
1 Chapter
Leukemia
Free
De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

0.00 Credits
1 Chapter
Leukemia
Free
New Strategies for MCL

New Strategies for MCL

0.00 Credits
1 Chapter
Leukemia
Free
AML and MDS: New Directions

AML and MDS: New Directions

0.00 Credits
1 Chapter
Leukemia
Free
Showing 25 of 58 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure